# Disparate Hepatic Mitochondrial and Inflammatory Effects of Ketone Supplements

**Authors:** Tyson J. Morris, Madeline D. Morris, Andrew J. Parker, Jeter R. Heggie, Eliza J. Roeth, Genevieve Parker, Matthew K. Beus, Rachel Ricks, T. Luke Shafer, Tyler S. Poulos, Dallin S. Nevers, Dominic P. D’Agostino, Juan A. Arroyo, R. Ryley Parrish, Paul R. Reynolds, Benjamin T. Bikman

PMC · DOI: 10.3390/nu18040675 · Nutrients · 2026-02-19

## TL;DR

This study compares how different ketone supplements affect liver mitochondria and inflammation in mice, finding that 1,3-butanediol causes significant stress while BHB enantiomers are safer.

## Contribution

The study reveals distinct hepatic effects of D-BHB, L-BHB, and 1,3-butanediol supplements, emphasizing the safety of BHB enantiomers versus the harmful effects of BD.

## Key findings

- L- and D-BHB increased ATP levels, while BD caused ATP depletion.
- BD significantly increased oxidative stress and inflammation markers compared to controls.
- BD reduced mitochondrial complex II activity and increased hepatic triglycerides after 8 days.

## Abstract

Background/Objectives: Beta-hydroxybutyrate (BHB) exists as two enantiomers with potentially distinct biological activities. While D-BHB is the physiological form produced during ketogenesis, L-BHB is present in equal amounts in racemic supplements, yet its biological effects remain poorly understood. Additionally, the ketone precursor 1,3-butanediol (BD) is used in some formulations despite limited safety data. Methods: We investigated acute (single gavage, 2-h time course) and short-term (daily gavage for 8 days) hepatic effects of D-BHB, L-BHB, and 1,3-butanediol compared to a vehicle control in male C57BL/6 mice. Acute studies assessed hepatic ATP dynamics and lipid peroxidation (MDA) at multiple timepoints. Eight-day protocols evaluated mitochondrial function (oxygen consumption, Complex II activity, SDH activity), lipid accumulation (triglycerides), and inflammatory markers (IL-1β, TNF-α, CRP). Results: Acute ATP responses differed markedly among treatments. Compared to the baseline and the control, L- and D-BHB elicited significant increases in ATP, while BD caused sustained ATP depletion. Over this same time, oxidative stress markers remained stable in the control and both BHB groups but increased dramatically with BD. After 8 days, the mitochondrial effects of BD were more apparent with a significant reduction in complex II-supported respiration and activity. Both forms of BHB maintained control levels of inflammation and BD showed significant effects on all inflammatory markers. Hepatic triglycerides increased only with BD treatment. Conclusions: This study reveals striking hepatic effects of various ketone supplements. In contrast to the positive or inert effects of BHB enantiomers, 1,3-butanediol induces significant hepatic stress. These findings have implications for ketone supplement formulation and highlight the therapeutic potential of D- and L-BHB.

## Linked entities

- **Proteins:** IL1B (interleukin 1 beta), TNF (tumor necrosis factor), CRP (C-reactive protein)
- **Chemicals:** Beta-hydroxybutyrate (PubChem CID 441), 1,3-butanediol (PubChem CID 7896), BD (PubChem CID 7896), MDA (PubChem CID 1614)

## Full-text entities

- **Genes:** Sds (serine dehydratase) [NCBI Gene 25044] {aka RATSDHE1, SDH2, Sdh, Sdhe1, TDH}, Crp (C-reactive protein, pentraxin-related) [NCBI Gene 12944], Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Mcph1 (microcephaly, primary autosomal recessive 1) [NCBI Gene 244329] {aka 5430437K10Rik, BRIT1, D030046N04Rik, MCT, Tg(HLA-A2.1)1Enge}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Hcar2 (hydroxycarboxylic acid receptor 2) [NCBI Gene 80885] {aka Gpr109a, Gpr109b, HM74, Niacr1, PUMA-G, Pumag}, Sds (serine dehydratase) [NCBI Gene 231691] {aka 4432411H13Rik, SDH}, Akr1a1 (aldo-keto reductase family 1, member A1) [NCBI Gene 58810] {aka 2610201A18Rik, Akr1a4}
- **Diseases:** NAFLD (MESH:D065626), cardiovascular disease (MESH:D002318), vascular congestion (MESH:D002311), toxicity (MESH:D064420), hepatic insulin resistance (MESH:D007333), metabolic acidosis (MESH:D000138), Inflammatory (MESH:D007249), Impaired hepatic ketogenesis (MESH:D008107), injury to (MESH:D014947), narcotic effects (MESH:D000079524), metabolic syndrome (MESH:D024821), II (MESH:C537730), impaired mitochondrial function (MESH:D028361), dislocation (MESH:D004204), BD (MESH:C537153), ketosis (MESH:D007662), hepatic sinusoidal dilation (MESH:D006504), alcoholic liver disease (MESH:D008108), hepatic steatosis (MESH:D005234), inflammatory cytokines (MESH:D000080424), depression (MESH:D003866), alcoholic fatty liver disease (MESH:D005235), Hepatic (MESH:D056486)
- **Chemicals:** lactate (MESH:D019344), nitrogen (MESH:D009584), MDA (MESH:D015104), Ketone (MESH:D007659), ADP (MESH:D000244), acetoacetate (MESH:C016635), Triglyceride (MESH:D014280), TCA (MESH:D014238), succinyl-CoA (MESH:C012046), carbohydrate (MESH:D002241), fatty acid (MESH:D005227), MDA (MESH:D008315), beta-hydroxybutyraldehyde (MESH:C116609), carbon (MESH:D002244), phosphocreatine (MESH:D010725), succinate (MESH:D019802), pyruvate (MESH:D019289), BHB (MESH:D020155), MgCl2 (MESH:D015636), D,L-BHB (-), 1,3-Butanediol (MESH:C028491), TG (MESH:D013866), O2 (MESH:D010100), DTT (MESH:D004229), NAD+ (MESH:D009243), glutamate (MESH:D018698), perchloric acid (MESH:C576518), TBARS (MESH:D017392), alcohol (MESH:D000438), malate (MESH:C030298), ketone bodies (MESH:D007657), ethanol (MESH:D000431), glucose (MESH:D005947), saponin (MESH:D012503), ROS (MESH:D017382), aldehyde (MESH:D000447), Ca (MESH:D002118), imidazole (MESH:C029899), ATP (MESH:D000255), taurine (MESH:D013654), EGTA (MESH:D004533), citrate (MESH:D019343), glutathione (MESH:D005978), isoflurane (MESH:D007530), Lipid (MESH:D008055), acetyl-CoA (MESH:D000105)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942913/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942913/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942913/full.md

---
Source: https://tomesphere.com/paper/PMC12942913